Serial Entrepreneur Tackles Stigma of Hormone Optimization

Hormone replacement therapy (HRT) is gradually stepping out of the shadows and into the limelight as renowned celebrities like Oprah and Drew Barrymore share their experiences with perimenopause. Yet, a shroud of stigma still envelopes HRT, especially concerning men with low testosterone levels. Now, Jason Whitson, a serial entrepreneur and former Under Armour executive, has embarked on a mission to break these barriers of bias.

Years ago, an incapacitating back injury plunged Whitson into a world of depression and stagnation. After realizing his slow recovery stemmed from shockingly low testosterone levels, he turned to a hormone optimization program. The transformation was profound, effectively transmuting his life’s trajectory. His experience ignited a passion for abolishing the stigma around HRT and improving access to it. Consequently, Whitson co-founded Wellcore, a scientifically-backed, at-home hormone optimization program.

Wellcore stands distinct in its approach, offering a uniquely painless HRT program designed to ensure individuals have the strength and vitality for a fulfilled life. The program includes a painless at-home blood collection device and an auto-injector for testosterone injections that can be conducted safely in the privacy of a home. A testament to Whitson’s innovative spirit, Wellcore reflects the entrepreneurship that led to his previous venture, Gritness, a fitness technology startup acquired by Under Armour.

“Most people over age 35 have sub-optimal hormone levels. There’s nothing wrong with fixing it,” Whitson asserts, aiming to change the narrative around hormone optimization. He believes in the importance of staying informed about the latest research, advising everyone aged 30 and above to get their hormones checked. “If you’re not willing to optimize them, you are setting yourself up for an uphill battle when it comes to your overall health and wellness,” Whitson adds.

The greatest challenge faced by Wellcore is the persistent stigma around HRT. Whitson empathizes with women who have endured a turbulent journey in hormone optimization due to poorly conducted studies in the past. He assures that Wellcore is equipped to help both genders navigate their hormone health optimally.

Wellcore’s uniqueness extends beyond offering a painless experience. It’s personalized and premium. The service provides a detailed assessment by examining nearly two dozen biomarkers, a significant enhancement over its competitors. All aspects of Wellcore, from its website to patient communications, exude a premium feel, ensuring its position as the preferred service provider in the HRT space.

Wellcore’s program includes proactive quarterly hormone assessments in the first year, followed by biannual assessments for ongoing optimization and safety. The science-backed protocols are drawn from data across 120 studies, offering reliable and tailored medical guidance to patients.

Startling statistics underscore the relevance and necessity of such a program. A Cleveland Clinic study recently debunked the myth of testosterone therapy raising heart risks, while current data reveals around 40% of US men aged 45+ suffer from low testosterone. Furthermore, the global HRT market is expected to surge by a staggering 152,270% by 2030, indicating an imminent shift in the healthcare landscape.

Whitson’s mission with Wellcore is clear – to normalize the conversation around HRT and to obliterate the stigma associated with it. By offering a robust, scientifically-backed, and accessible solution, Wellcore is paving the way for a future where hormonal health is prioritized and optimized, minus the fear and prejudice.